Abstract:Objective To explore treatment strategy of pancreatic pseudocyst induced left-sided portal hypertension (LSPH) complicated with hypersplenism. Methods The clinical data of 49 cases of pancreatic pseudocyst induced LSPH complicated with hypersplenism from January 2010 to June 2015 in this hospital were retrospectively analyzed. Among them, 36 patients who were not complicated with upper gastrointestinal bleeding were designed to splenectomy group and non-splenectomy group based on splenectomy or not. The epidemiological and clinical features, intraoperative and postoperative results of these two groups were compared. Results There were 38 males and 11 females with age ranging from 22 to 67 years old. As for 13 patients suffering LSPH complicated with hypersplenism caused by pancreatic pseudocyst with upper gastrointestinal bleeding, one patient didn't accept splenectomy, then the upper gastrointestinal bleeding recurred and the hypersplenism was not alleviated after operation; Whereas, the hypersplenisms were relieved in the others patients after operation. In the 36 patients without upper gastrointestinal bleeding who were complicated with hypersplenism, 23 patients were performed splenectomy (splenectomy group) and 13 patients were not (non-splenectomy group). In the splenectomy group, the blood loss, operation time, and intraoperative blood transfusion were significantly more than those of the non-splenectomy group (P<0.05). The hospital stay and the discharged laboratory examinations had no significant differences between the splenectomy group and the non-splenectomy group (P>0.05) except for the platelet count. Furthermore, the incidence of the postoperative upper gastrointestinal bleeding was lower (P<0.05) and the relief rate of hypersplenism was higher (P<0.05) in the splenectomy group as compared with the non-splenectomy group. Conclusions For pancreatic pseudocyst induced LSPH with hypersplenism, we should be vigilant and early intervent. Usually, primary focus can be treated only. However, splenectomy can effectively relieve hypersplenism and prevent recurrent bleeding for patients with upper gastrointestinal bleeding or patients with close adhesion of pancreas tail and spleen inflammatory lesions and constricting splenic hilus.

Treatment of hypersplenism in patients with portal hypertension of hepatic cirrhosis

[Laparoscopic Splenectomy and Pericardial Devascularization for Treatment of Portal Hypertension Due to Liver Cirrhosis].

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

A Comparative Study of Surgical Splenectomy, Partial Splenic Embolization, and High-Intensity Focused Ultrasound for Hypersplenism.

Percutaneous Microwave Ablation in the Spleen for Treatment of Hypersplenism in Cirrhosis Patients

[Treating Portal Hypertension by Subtotal Splenectomy with Retroperitoneal Splenic Transposition and Devascularization: Clinical Study].

Clinical Evaluation on Effect of Partial Splenic Embolization in Treatment of 112 Patients with Hepatic Cirrhosis and Hypersplenism

Clinical analysis of diverse treatment for hepatocellular carcinoma with hypersplenism

Partial splenic embolization for liver cirrhosis accompanied by hypersplenism: an analysis of 39 cases

Which patients are likely to have a persistent hypersplenism after liver transplantation for the treatment of dysfunctional liver cirrhosis and hypersplenism

Surgical treatment for hepatocellular carcinoma and secondary hypersplenism.

Treatment strategy of left-sided portal hypertension complicated with hypersplenism caused by pancreatic pseudocyst

Splenic artery embolization with detachable balloons for hypersplenism

Partial splenic embolization with sodium alginate microspheres for hypersplenism in cirrhosis

Clinical Application of Gastroesophageal Varices Embolization Combined with Partial Splenic Embolization in Portal Hypertension

Effects of hypersplenism on the outcome of hepatectomy in hepatocellular carcinoma with hepatitis B virus related portal hypertension

Rmhp_a_234628 135..140

Total Embolization of the Main Splenic Artery As a Supplemental Treatment Modality for Hypersplenism

Effects Of Entecavir, Partial Splenic Artery Embolization, And Salvia Miltiorrhiza On Patients With Hypersplenism Due To Hepatitis B Virus-Related Cirrhosis

Splenectomy And Selectively Devascularization For Esophageal Bleeding Secondary To Portal Hypertension

[Radiofrequency Ablation for Hypersplenism Due to Portal Hypertension: Clinical Study].